Characterization of a calcium-dependent calmodulin-binding domain in the 135-kD human protein 4.1 isoform

Eur J Biochem. 1998 Dec 1;258(2):567-71. doi: 10.1046/j.1432-1327.1998.2580567.x.

Abstract

The putative calmodulin binding domain of non-erythroid protein 4.1, previously suggested by Kelly et al. [Kelly, G. M., Zelus, B. D. & Moon, R. T. (1991) J. Biol. Chem. 266, 12469-12473] has been synthesized, and its binding to calmodulin has been studied by fluorescence spectroscopy. For this purpose, the peptide has been N-terminally dansylated. The 4.1 peptide Dns-Abu-S76RGLSRLFSSFLKRPKS92, binds calmodulin in a calcium-dependent way with high affinity (Kd = 23 +/- 6 nM). The peptide inhibits bovine-heart phosphodiesterase with an IC50 of 50 nM. Since the sequence of the peptide shows two putative consensus sites of phosphorylation by cAMP-dependent protein kinase or Ca2+-calmodulin protein-kinase II, the interaction of the two mono-phosphorylated peptides (P4.1 Ser(80-P) and P4.1 Ser(84-P)) and the di-phosphorylated peptide (P4.1 Ser(80-P)/Ser(84-P)) with calmodulin has been investigated. A decrease of affinity by a factor 1.5-8 has been observed for the phosphorylated peptides. CD measurements have shown an increase of the content of alpha helices in the peptides when bound to calmodulin.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Calcium / pharmacology
  • Calmodulin-Binding Proteins / chemistry*
  • Cattle
  • Circular Dichroism
  • Cyclic AMP / metabolism
  • Cytoskeletal Proteins*
  • Humans
  • Membrane Proteins / chemistry*
  • Molecular Sequence Data
  • Myocardium / enzymology
  • Neuropeptides*
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology
  • Phosphodiesterase Inhibitors / pharmacology
  • Phosphopeptides / metabolism
  • Phosphorylation
  • Phosphoserine / metabolism
  • Protein Binding / physiology
  • Spectrometry, Fluorescence

Substances

  • Calmodulin-Binding Proteins
  • Cytoskeletal Proteins
  • Membrane Proteins
  • Neuropeptides
  • Peptide Fragments
  • Phosphodiesterase Inhibitors
  • Phosphopeptides
  • erythrocyte membrane band 4.1 protein
  • erythrocyte membrane protein band 4.1-like 1
  • Phosphoserine
  • Cyclic AMP
  • Calcium